Exploring Novel Molecular Targets in Basal Cell Carcinoma Treatment

Basal cell carcinoma (BCC) is the most prevalent skin cancer globally, primarily resulting from chronic UV exposure and characterized by its slow growth. While hedgehog pathway inhibitors, such as vismodegib and sonidegib, have revolutionized BCC management, their use is limited by drug resistance and adverse effects. Consequently, ongoing research is focusing on identifying new molecular targets that may provide alternative therapeutic options.Understanding BCC BiologyBCC arises from the transformation of basal keratinocytes in the epidermis. The hedgehog signaling pathway plays a critical role in the proliferation and survival of these cells. However, in recent years, scientists have observed that not all BCCs are reliant on this pathway. This realization has prompted investigations into other molecular pathways and targets that could be exploited for therapeutic purposes.Emerging Molecular TargetsRecent studies have identified several promising molecular targets in BCC that extend beyond the hedgehog pathway:PI3K/Akt/mTOR pathway: This signaling cascade is vital for cell growth and survival. Research has shown that aberrations in this pathway contribute to BCC pathogenesis. Inhibitors targeting this pathway may offer new treatment avenues.CDK4/6 inhibitors: Cyclin-dependent kinases 4 and 6 (CDK4/6) regulate cell cycle progression. Preclinical studies have demonstrated that targeting these kinases may impede BCC growth and overcome hedgehog resistance.Immune checkpoint inhibitors: The role of the immune system in cancer treatment has become increasingly recognized. Agents targeting PD-1 and CTLA-4 have shown promise in other malignancies, and their application in BCC is being actively researched.Histone deacetylase (HDAC) inhibitors: Aberrant epigenetic modifications play a role in many cancers, including BCC. HDAC inhibitors are being evaluated for their potential to reverse these changes, thereby affecting tumor growth and progression.Clinical ImplicationsThe id